Navigation Links
Mylan Reports Third Quarter 2013 Adjusted Diluted EPS of $0.82
Date:10/31/2013

>

1.70.44.21.1Generics total revenues

1,406.11,495.84,279.64,390.2Specialty:Third party net sales

357.2301.8805.7679.418

%18

%19

%19

%Other third party revenues

5.84.519.54.7Total third party revenues

363.0306.3825.2684.1Intersegment revenues

4.16.518.030.1Specialty total revenues

367.1312.8843.2714.2Elimination of intersegment revenues

(5.8)(6.9)(22.2)(31.2)Consolidated total revenues

$

1,767.4$

1,801.7$

5,100.6$

5,073.2(2)%—

%1

%2

%(1) The constant currency percent change is derived by translating third party net sales for the current period at prior year comparative period exchange rates.Note
Beginning with the first quarter of 2013, the Company reorganized the components of its Generics and Specialty segments as a result of a change in the way the Chief Executive Officer, who is the chief operating decision maker, evaluates the performance of operations, develops strategy and allocates capital resources. As required by the applicable accounting standards, financial statements issued subsequent to this segment reporting change are required to reflect modifications to the reportable segment information resulting from the revision, including reclassifications of all comparative segment information. Accordingly, this earnings release reflects the change in segment reporting for all periods presented. There is no change to the Company's previously reported consolidated net operating results, financial position or cash flows. Mylan Inc. and SubsidiariesReconciliation of Non-GAAP Financial Measures(Unaudited; in millions)Three Months EndedNine Months EndedSeptember 30,September 30,2013201220132012GAAP cost of sales$

958.9$

1,008.7$

2,856.2$

2,907.3Deduct:Purchase accounting related amortization

(85.1)(128.7)(
'/>"/>

SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related medicine technology :

1. Mylan Supports Generic Drug Industrys Call on FDA to Uphold Consistent, Proven International Standard for Biosimilar Naming
2. Mylan to Speak at the Morgan Stanley Global Healthcare Unplugged Conference
3. Mylan to Speak at the Bank of America Merrill Lynch Global Healthcare Conference
4. Mylan Announces Completion of Transdermal Patch Facility Expansion Project in St. Albans, Vt.
5. Mylan Acquisition of Agila Receives Approval from Indias Foreign Investment Promotion Board and Cabinet Committee on Economic Affairs
6. Mylan Confirms Approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg
7. Mylan Reports a 13% Increase in Second Quarter 2013 Adjusted Diluted EPS to $0.68
8. Third Circuit Rules in Mylans Favor Regarding Paroxetine Hydrochloride Extended-Release Tablets, Sending Mylans Breach of Contract Claim Against GSK to Trial
9. Mylan to Host Investor Day on Aug. 1, 2013 in New York City
10. Roger Graham Named President of Mylan Specialty
11. Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... AUSTIN, Texas , Jan. 14, 2014  Luminex Corporation (Nasdaq: ... report results for the fourth quarter of 2013 on Monday, ... scheduled for release after the close of trading. ... a conference call to discuss the operating highlights and financial ...
(Date:1/14/2014)... 2014 Dynamic Healthcare Services, Inc. ("DHS"), a portfolio company ... Progressive Home Medical Equipment, Inc. ("Progressive") of Clarion, ... the acquisition were not disclosed. Progressive is ... wide range of sleep, mobility, and respiratory products to customers ...
(Date:1/14/2014)... , a manufacturer of ergonomically designed laboratory equipment for ... Japan to sell and service the Hitachi ... will utilize its network of sales professionals throughout the ... offer assistance in application use, product benefits and features, options and ...
Breaking Medicine Technology:Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
(Date:4/17/2014)... Experimental Biology and Medicine a multidisciplinary ... Paul Kenis in the Institute of Genomic Biology ... Illinois Urbana-Champaign describe their recent work on subcellular ... of cell functions including energy metabolism, signaling, and ... regulating normal cellular behavior, redox status has been ...
(Date:4/17/2014)... a review published in the April issue of ... Feinstein Institute for Medical Research, says it,s time to ... approach to treating sepsis, which kills millions worldwide ... occurs when molecules released into the bloodstream to fight ... Inflammation is necessary for maintaining good health without ...
(Date:4/17/2014)... personnel who served in Iraq and Afghanistan and ... (TBI) were compared to military personnel without TBI ... in measures of overall disability, cognitive function, post-traumatic ... reported in an article in Journal of ... Liebert, Inc., publishers. The article is available free ...
(Date:4/17/2014)... 2014) The cause of neuronal death in Parkinson,s ... that neurons may be mistaken for foreign invaders and ... the way autoimmune diseases like type I diabetes, celiac ... study was published April 16, 2014, in Nature ... controversial, idea in Parkinson,s disease; but if true, it ...
(Date:4/17/2014)... (BUSM) have discovered that the anti-seizure drug ezogabine, ... findings, reported in the American Journal of ... more effective treatments for alcoholism. , Excessive consumption ... of illness and death in the U.S. and ... productivity of workers and necessitating huge health care ...
Breaking Medicine News(10 mins):Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Is Parkinson's an autoimmune disease? 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2
... and director of the Walter and Eliza Hall Institute, ... Australia Leadership and Innovation Award. The award recognises ... as his leadership in promoting the value of health ... Hilton,s scientific career has focussed on the control of ...
... , WEDNESDAY, Nov. 16 (HealthDay News) -- Overall outpatient ... 12 percent between 1999 and 2007, but alarmingly high ... antibiotic-resistant bacteria, researchers warn. The findings were ... Center for Disease Dynamics, Economics & Policy in Washington, ...
... cardiovascular disease who have a genetic variation that diminishes ... standard daily dosage of this medication resulted in improved ... JAMA . The study is being released early online ... Association Scientific Sessions. "Variants in the CYP2C19 ...
... tolerability of the breast cancer drug tamoxifen in male breast ... therapy early because of problems with side effects caused by ... published today in the cancer journal Annals of Oncology ... patients at their institution who had received tamoxifen for an ...
... New York State Senator Jeffrey ... Albert Einstein College of Medicine of Yeshiva University last ... Neurophysiology Laboratory . Several pieces of high-tech diagnostic and ... equipment and specialized video recording devices, were purchased through ...
... By Denise Mann HealthDay Reporter , TUESDAY, Nov. ... at higher risk than brainiacs for later weight gain and added ... had the lowest IQs at about age 18 had higher waist-to-hip ... those IQ tests. It,s known that people with "apple-shaped" bodies, or ...
Cached Medicine News:Health News:Professor Doug Hilton wins Research Australia Award 2Health News:Increasing dosage of clopidogrel for patients with genetic variation improves response to medication 2Health News:Male breast cancer patients stop taking tamoxifen early because of drug-related side effects 2Health News:Male breast cancer patients stop taking tamoxifen early because of drug-related side effects 3Health News:State Sen. Jeff Klein launches Einstein's new lab 2Health News:Study Finds Link Between Low IQ, Large Waistline 2Health News:Study Finds Link Between Low IQ, Large Waistline 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: